Article Open Access Volume 2 · Issue 1 · 2023 pp. 24–26

Pericardial Tamponade Due to Methotrexate Toxicity: A Case Report

Mustafa Ahmet Afacan1, İsmail Tayfur2, Burcu Genç Yavuz1, Özlem Tataroğlu3
1 University of Health Sciences Turkey, Haydarpaşa Numune Training and Research Hospital, Clinic of Emergency Medicine, İstanbul, Turkey
2 University of Health Sciences Turkey, Sancaktepe Prof. Dr. İlhan Varank Training and Research Hospital, Clinic of Emergency Medicine, İstanbul, Turkey
3 University of Health Sciences Turkey, Kartal Dr. Lütfi Kırdar Training and Research Hospital, Clinic of Emergency Medicine, İstanbul, Turkey
Published: 2023 DOI: 10.4274/globecc.galenos.2022.76486 Article ID: GECC-30307
Abstract
Methotrexate (MTX) is a folic acid analog that inhibits the growth of rapidly proliferating cells, such as bone marrow or cancer cells, through its anti-inflammatory and anti-proliferative properties. With these characteristics, using MTX for treating moderate or severe psoriatic arthritis results in a significant improvement in the health of patients with this condition. Although MTX has many side effects, pericardial tamponade is a very rare complication. Rapidly progressing tamponade is associated with high morbidity and mortality. Here, we present a case of pericardial tamponade in a 69-year-old female patient due to MTX use and its possible facilitating effect.

Keywords: Methotrexate, psoriatic arthritis, pericardial tamponade

Article information

Download PDF

Journal cover Vol 2 · Iss 1

Global Emergency and Critical Care – Issue cover
Submit manuscript
Most read & early access
Click an article to open abstract. Numbers indicate total views or downloads.
View all articles